Popular Articles

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data For AM211, A Novel Product Candidate For The Treatment Of Respiratory Diseases
Amira Pharmaceuticals, Inc. announced initial positive data from a Phase 1 clinical study of AM211, the company"s oral selective antagonist of the DP2 (also known as CRTH2) receptor.
pharmacy online
New York Lawmakers Should Pass Bill Capping Amount Low-Income Residents With HIV Pay For Housing, Columnist Says
Some New York City residents with HIV pay as much as 70% of their income on housing because of the financial assistance they receive through the New York City HIV/AIDS Services Administration, New York Daily News columnist Errol Louis writes. According to Louis, lawmakers should pass a bill that would cap the rent contribution of low-income people with HIV/AIDS at 30% of their income, "the standard used for most rent-subsidy programs." The bill is currently before the state"s Assembly Ways and Means Committee. Louis adds that ensuring that people living with HIV are in "stable housing ò€¦ makes them less likely to run up big taxpayer bills by using public hospital emergency rooms for basic health care." He concludes, "Albany has a choice: do what"s cheap and quick in the short run, or do what makes long-term sense and saves lives" (Louis, New York Daily News, 5/31).
News of the day
A Feasible, Simple And Convenient Model For Study Of Rectal Carcinoma
The method of building a rabbit rectal VX2 carcinoma model by injecting the cell suspension of VX2 cells into the wall of the rectum guided by X-ray fluoroscopy is feasible. The advantages of the model are ease of establishment, short growth period, and high stability. The rectal VX2 carcinoma established in this rabbit model is similar to human rectal carcinoma in aspects of pathological representation, tumor development, and metastasis. It offers an ideal major animal model for the study of rectal carcinoma, and especially profits the study of the staging of rectal carcinoma in imaging.
Endocrinology

Southampton University Hospitals NHS Trust Hosts National Conference On Infection Prevention, UK

Southampton University Hospitals NHS Trust is to host a national conference on combating infections. The infection prevention team will look at various products assessed at Southampton General Hospital and the Princess Anne to tackle bugs. The Trust is one of eight Showcase Hospitals within the UK currently evaluating the implementation of new technologies and equipment with the potential to fight Health Care Associated Infection (HCAI). The event, which takes place at the Novotel hotel tomorrow today, will include talks from expert speakers who have been involved in the project and an exhibition of various companies. Mary O"Leary, Showcase Hospitals project lead at SUHT, said: "We are very proud to be hosting this conference and hope it will prove useful in continuing to raise the profile of our fight against infection throughout the Trust." The project is part of the HCAI Technology Innovation Programme supported by the Department of Health. Southampton University Hospitals NHS Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):